John Kenneth Amory

No ORCID on file · 1 paper in corpus

nonrandomized-trial 2009

Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics

Cancer chemotherapy and pharmacology ·doi:10.1007/s00280-009-1038-1

PURPOSE: GnRH analogs are useful for the treatment of prostate cancer, but require parenteral administration. The peptide GnRH antagonist acyline potently suppresses luteinizing hormone (LH) and testosterone in man; however, its clinical ut…